SCHEMBL14798294

SCHEMBL14798294

Cc1ccccc1S(=O)(=O)N[C@H](C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.64
SLC1A2 P43004 1/20 0.64
SLC1A1 P43005 1/20 0.64
ADAMTS4 O75173 1/20 0.58
ITGAV P06756 2/20 0.57
CASP1 P29466 4/20 0.49
ITGA2 P17301 1/20 0.49
HTT P42858 2/20 0.49
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP3 P08254 1/20 0.48
MMP7 P09237 1/20 0.48
MMP9 P14780 1/20 0.48
MMP13 P45452 1/20 0.48
ALDH1A1 P00352 1/20 0.46
CYP2C19 P33261 1/20 0.46
KAT6A Q92794 1/20 0.44
ALOX5AP P20292 1/20 0.44
FEN1 P39748 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27895996 1.00 SLC1A3 (0.64) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL10765699 1.00 SLC1A3 (0.64) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL9276421 0.86 ADAMTS4 (0.50) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL1906773 0.85 SLC1A3 (0.58) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
Phenanthroline SCHEMBL27890313 0.84 SLC40A1 (0.56) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL4588941 0.84 SLC1A3 (0.74) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL3964633 0.84 SLC1A3 (0.74) SLC1A3SLC1A2SLC1A1ADAMTS4ITGAV
SCHEMBL15918110 0.82 ADAMTS4 (0.56) SLC1A3SLC1A2SLC1A1ADAMTS4HTT
SCHEMBL15923698 0.82 ADAMTS4 (0.56) SLC1A3SLC1A2SLC1A1ADAMTS4HTT
SCHEMBL27388236 0.82 ADAMTS4 (0.56) SLC1A3SLC1A2SLC1A1ADAMTS4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9265768-B2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-02-23 US disclosed
EP-2760838-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2014-08-06 EP disclosed
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-05-22 US disclosed
WO-2013045280-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-04-04 WO disclosed
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079313-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A SLC1A3 3975/4885SLC1A2 4188/4885SLC1A1 4070/4885
US-20140142074-A1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A SLC1A3 3975/4885SLC1A2 4188/4885SLC1A1 4070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.